2Hypoglycemic coma in type diabetes refers to patients with2A potential complication that may occur in patients with type diabetes. Patients treated with insulin or long-acting sulfonylurea drugs have a high risk of hypoglycemia, especially the elderly and those with renal insufficiency, who are prone to hypoglycemia at night. Normally, the body maintains blood sugar within a relatively narrow range through complex, systematic and precise regulatory mechanisms. Once an individual exceeds the utilization of glucose over the supply of glucose for some reason, breaks the stability of the body's blood sugar internal environment, the plasma glucose concentration begins to decrease, such as: an increase in insulin or insulin-like substances in the blood; insufficient cortisol, glucagon, growth hormone and adrenaline, etc., hormones that increase blood sugar; severe insufficient intake and (or) absorption of sugar; insufficient glycogen reserve and (or) decomposition disorders; excessive consumption of glucose by tissues and a decrease in glycogenolysis, etc.
It is generally believed that the standard for hypoglycemia is: plasma glucose concentration less than2.8mmol/L(50mg/dl).Hypoglycemia is the most common problem in the treatment of diabetes, and it should be avoided as much as possible. If hypoglycemia has no harmful effects on the human body, especially the brain, the treatment of diabetes is extremely simple. Just use a sufficient amount of insulin or sulfonylurea drugs to lower blood sugar, which can alleviate the symptoms caused by hyperglycemia, prevent acute and chronic complications such as retinopathy, kidney and neuropathy, and reduce the risk factors of atherosclerosis.